Explainable machine learning model for predicting acute pancreatitis mortality in the intensive care unit
Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitte...
Saved in:
Published in | BMC gastroenterology Vol. 25; no. 1; pp. 131 - 11 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
03.03.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.
A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.
The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.
This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. |
---|---|
AbstractList | Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.BACKGROUNDCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.METHODSA gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.RESULTSThe XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.CONCLUSIONSThis model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. Methods A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. Results The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. Conclusions This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Keywords: Acute pancreatitis, Prognostic factor, XGBoost, Mortality, Prediction BackgroundCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.MethodsA gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.ResultsThe XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84–0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.ConclusionsThis model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Abstract Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. Methods A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. Results The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84–0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. Conclusions This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. |
ArticleNumber | 131 |
Audience | Academic |
Author | Jiang, Meng Wu, Xiao-peng Li, Chang-li Lin, Xing-chen |
Author_xml | – sequence: 1 givenname: Meng surname: Jiang fullname: Jiang, Meng – sequence: 2 givenname: Xiao-peng surname: Wu fullname: Wu, Xiao-peng – sequence: 3 givenname: Xing-chen surname: Lin fullname: Lin, Xing-chen – sequence: 4 givenname: Chang-li surname: Li fullname: Li, Chang-li |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40033198$$D View this record in MEDLINE/PubMed |
BookMark | eNptkkFv3CAQha0qVZNs-wd6qCz10otTMGDwqYqiJI0UqZdW6g2N8XiXlQ1bwFHy74uzaZqtKg6Dho8HD95pceS8w6J4T8kZpar5HGmtZFORWlSEyZpV7FVxQrmkVc3Iz6MX8-PiNMYtIVSqmr0pjjkhjNFWnRT28n43gnXQjVhOYDbWYTkiBGfdupx8j2M5-FDuAvbWpKUJZk5Y7sCZgJBssjFzIcFo00NpXZk2mEtCF-0dlgYClrOz6W3xeoAx4runuip-XF1-v_ha3X67vrk4v60M5yJVkjBsSMe4UpR22ZegPSBpGQFEppQybaOGoZad4ANpByZAYCs6kNgbxJ6tipu9bu9hq3fBThAetAerHxs-rDWEZM2ImqPqKOVgBuw4FQ3wBjpomOzbtu2VyFpf9lq7uZsWfZcCjAeihyvObvTa3-n8P1K2-dar4tOTQvC_ZoxJTzYaHEdw6OeoGZWMk4bLJqMf_0G3fg4uv9VCifxnioq_1BqyA-sGnw82i6g-V3UrRC34onX2HyqPHidrcowGm_sHGz68dPps8U9SMlDvARN8jAGHZ4SSxW6j93HUOY76MY6asd-S59JX |
Cites_doi | 10.1046/j.0007-1323.2001.02025.x 10.1159/000090032 10.1016/j.gie.2010.10.006 10.2307/2531595 10.1186/s12876-019-1016-y 10.1155/2021/5525118 10.1136/gut.2008.152702 10.1136/bmj.g7594 10.1145/2939672.2939785 10.1053/j.gastro.2007.03.065 10.1053/j.gastro.2019.09.009 10.7326/M16-0650 10.1186/s12876-021-01906-2 10.1136/gutjnl-2012-302779 10.1016/S0140-6736(20)31310-6 10.14309/ajg.0000000000000632 10.1186/s13017-019-0247-0 10.1016/j.pan.2013.07.063 10.1007/s10115-013-0679-x 10.1002/bjs.1800771120 10.1016/0022-4804(77)90045-2 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH H94 K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12876-025-03723-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Database Suite (ProQuest) ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-230X |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_4e8b114acfeb4156a46aba637d999d85 PMC11877909 A829552546 40033198 10_1186_s12876_025_03723_3 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: Fundamental Research Funds for the Central Universities grantid: 2022ZFJH003 – fundername: National Natural Science Foundation of China grantid: 82000478 – fundername: Natural Science Foundation of Zhejiang Province grantid: LMS25H180003 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7QR 7T5 7XB 8FD 8FK AZQEC DWQXO FR3 H94 K9. M48 P64 PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c445t-703e60b348811b03751dae0930aee3888c968ff27b54f09f35a5e95ba7edceed3 |
IEDL.DBID | 7X7 |
ISSN | 1471-230X |
IngestDate | Wed Aug 27 01:09:42 EDT 2025 Thu Aug 21 18:27:15 EDT 2025 Fri Jul 11 07:01:35 EDT 2025 Fri Jul 25 21:28:35 EDT 2025 Tue Jun 17 22:00:28 EDT 2025 Tue Jun 10 21:08:31 EDT 2025 Mon May 12 02:38:51 EDT 2025 Tue Jul 01 05:18:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Prognostic factor Acute pancreatitis Mortality XGBoost Prediction |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c445t-703e60b348811b03751dae0930aee3888c968ff27b54f09f35a5e95ba7edceed3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3175400815?pq-origsite=%requestingapplication% |
PMID | 40033198 |
PQID | 3175400815 |
PQPubID | 44673 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4e8b114acfeb4156a46aba637d999d85 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11877909 proquest_miscellaneous_3173406476 proquest_journals_3175400815 gale_infotracmisc_A829552546 gale_infotracacademiconefile_A829552546 pubmed_primary_40033198 crossref_primary_10_1186_s12876_025_03723_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-03-03 |
PublicationDateYYYYMMDD | 2025-03-03 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC gastroenterology |
PublicationTitleAlternate | BMC Gastroenterol |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | C Li (3723_CR1) 2021; 21 Q Qiu (3723_CR10) 2019; 19 3723_CR9 CB Pearce (3723_CR11) 2006; 6 A Leppäniemi (3723_CR23) 2019; 14 3723_CR24 3723_CR22 C Wilson (3723_CR6) 1990; 77 GS Collins (3723_CR12) 2015; 350 F Deshmukh (3723_CR16) 2020; 115 L Boxhoorn (3723_CR2) 2020; 396 E Strumbelj (3723_CR25) 2014; 41 M Motwani (3723_CR13) 2017; 38 PA Banks (3723_CR4) 2013; 62 CE Forsmark (3723_CR21) 2007; 132 3723_CR18 JH Ranson (3723_CR7) 1977; 22 A Buter (3723_CR3) 2002; 89 MY Di (3723_CR5) 2016; 165 3723_CR17 DL Shung (3723_CR15) 2020; 158 F Pedregosa (3723_CR19) 2011; 12 ER DeLong (3723_CR20) 1988; 44 G Rotondano (3723_CR14) 2011; 73 BU Wu (3723_CR8) 2008; 57 |
References_xml | – volume: 89 start-page: 298 issue: 3 year: 2002 ident: 3723_CR3 publication-title: Brit J Surg doi: 10.1046/j.0007-1323.2001.02025.x – volume: 6 start-page: 123 issue: 1–2 year: 2006 ident: 3723_CR11 publication-title: Pancreatology doi: 10.1159/000090032 – volume: 73 start-page: 218 issue: 2 year: 2011 ident: 3723_CR14 publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2010.10.006 – volume: 44 start-page: 837 issue: 3 year: 1988 ident: 3723_CR20 publication-title: Biometrics doi: 10.2307/2531595 – volume: 19 start-page: 118 issue: 1 year: 2019 ident: 3723_CR10 publication-title: BMC Gastroenterol doi: 10.1186/s12876-019-1016-y – ident: 3723_CR9 doi: 10.1155/2021/5525118 – volume: 57 start-page: 1698 issue: 12 year: 2008 ident: 3723_CR8 publication-title: Gut doi: 10.1136/gut.2008.152702 – volume: 350 start-page: g7594 year: 2015 ident: 3723_CR12 publication-title: BMJ doi: 10.1136/bmj.g7594 – ident: 3723_CR18 – ident: 3723_CR24 – ident: 3723_CR17 doi: 10.1145/2939672.2939785 – volume: 132 start-page: 2022 issue: 5 year: 2007 ident: 3723_CR21 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.065 – volume: 38 start-page: 500 issue: 7 year: 2017 ident: 3723_CR13 publication-title: Eur Heart J – volume: 158 start-page: 160 issue: 1 year: 2020 ident: 3723_CR15 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.09.009 – volume: 165 start-page: 482 issue: 7 year: 2016 ident: 3723_CR5 publication-title: Ann Intern Med doi: 10.7326/M16-0650 – volume: 12 start-page: 2825 year: 2011 ident: 3723_CR19 publication-title: JMLR – volume: 21 start-page: 332 issue: 1 year: 2021 ident: 3723_CR1 publication-title: BMC Gastroenterol doi: 10.1186/s12876-021-01906-2 – volume: 62 start-page: 102 issue: 1 year: 2013 ident: 3723_CR4 publication-title: Gut doi: 10.1136/gutjnl-2012-302779 – volume: 396 start-page: 726 issue: 10252 year: 2020 ident: 3723_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(20)31310-6 – volume: 115 start-page: 1657 issue: 10 year: 2020 ident: 3723_CR16 publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000632 – volume: 14 start-page: 27 year: 2019 ident: 3723_CR23 publication-title: World J Emerg Surg doi: 10.1186/s13017-019-0247-0 – ident: 3723_CR22 doi: 10.1016/j.pan.2013.07.063 – volume: 41 start-page: 647 year: 2014 ident: 3723_CR25 publication-title: Knowl Inf Syst doi: 10.1007/s10115-013-0679-x – volume: 77 start-page: 1260 issue: 11 year: 1990 ident: 3723_CR6 publication-title: Brit J Surg doi: 10.1002/bjs.1800771120 – volume: 22 start-page: 79 issue: 2 year: 1977 ident: 3723_CR7 publication-title: J Surg Res doi: 10.1016/0022-4804(77)90045-2 |
SSID | ssj0017823 |
Score | 2.3974879 |
Snippet | Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine... Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a... BackgroundCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a... Abstract Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 131 |
SubjectTerms | Acute Disease Acute pancreatitis Adult Aged Algorithms Analysis APACHE Care and treatment China Clinical medicine Datasets Development and progression Female Forecasts and trends Health aspects Hospital Mortality Humans Intensive care Intensive Care Units Learning algorithms Machine Learning Male Medical research Medicine, Experimental Methods Middle Aged Missing data Mortality Online databases Pancreatitis Pancreatitis - mortality Patient admissions Patients Prediction Prediction models Prevention Prognosis Prognostic factor Risk Assessment - methods Risk groups ROC Curve Severity of Illness Index Triage (Medicine) Vital signs XGBoost |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh5JLadq02TQtKgR6KCa29T4mpSEU0lMCuQlJllof4oSs9_93RpaXNTnkUvDJGj-kmdF8Y8-DkNPgTSOciZXLKTmoikbrUHHGA0tKCePwg_71b3l1y3_dibudVl8YEzaVB54W7oxH7QGzu5CiR2fDcem8k0x1AG06nauXgs2bnany_wDsHptTZLQ8W8MurDDYVlQ1Uy2r2MIM5Wr9z_fkHaO0DJjcsUCXb8mbAh3p-fTKB-RVHN6R19fl5_h70mM8XUmGovc5SDLS0hXiD80tbyhAVPr4hJdguDN1YTNGChvChB3Hfg10iMcBm9N-oIAOaT8HuVOMEqMb2AMOye3lz5sfV1XppFAFzsVYgVpHWXsG2to0HtveNp2LtWG1i5GBExyM1Cm1ygueapOYcCIa4Z3COceOfSB7w8MQjwgFByTJTrKUYges5S6Bh-U6mYxsdafYinyfF9Y-TgUzbHY0tLQTGyywwWY2WKC-wLXfUmKx63wCRMAWEbAvicCKfEPOWVRJYE9wJbMAXhiLW9lz3RohsPD_ipwsKEGVwnJ45r0tqry2CLA4Iid4ztftMF6J4WlDfNhkGsYxbRdu8XESle2UOLbLa4xeEb0QosWclyND_zcX-sZW8MrU5vh_rNInst9OCgDHCdkbnzbxMwCq0X_JuvMP51UejA priority: 102 providerName: Directory of Open Access Journals |
Title | Explainable machine learning model for predicting acute pancreatitis mortality in the intensive care unit |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40033198 https://www.proquest.com/docview/3175400815 https://www.proquest.com/docview/3173406476 https://pubmed.ncbi.nlm.nih.gov/PMC11877909 https://doaj.org/article/4e8b114acfeb4156a46aba637d999d85 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0nc3TRcVCj0UE9t6n0q2JIRCQgkNLL0I2ZYSH-rd7nr_f2ZkeRtTKBgfrLGxPJqX_M0MIZ_qyhTCGZ-5mJKDomi0rjPOeM2CUsI43NC_vJIXN_z7UizThts2wSpHnRgVdbOqcY_8BO0cRwMmvq7_ZNg1Cv-uphYaj8khli5DSJda7gOuAqwfGxNltDzZgi5WCLkVWc5UyTI2MUaxZv-_mvmBaZrCJh_YofPn5FlyIOnpwPEX5JHvXpInl-kX-SvSIqoupUTR3xEq6WnqDXFLY-MbCo4qXW_wFgQ9U1fvek9BLQweZN9ugQ69cvDQadtR8BFpO0LdKWLF6A40wWtyc37289tFlvopZDXnos9AuL3MKwYyWxQVNr8tGudzw3LnPYNQuDZSh1CqSvCQm8CEE96Iyimcs2_YG3LQrTr_jlAIQ4JsJAvBN8Bg7gLEWa6RwchSN4rNyJfxw9r1UDbDxnBDSzuwwQIbbGSDBeoFfvs9JZa8jhdWm1ubJMhyrysI3lwdfIVRp-PSVU4y1YCP22gxI5-RcxYFE9hTu5RfAC-MJa7sqS6NEFj-f0aOJ5QgUPV0eOS9TQK9tX-X34x83A_jnQhS6_xqF2kYx-RdeMTbYansp8SxaV5h9IzoySKazHk60rV3sdw3NoRXJjdH_3-v9-RpOSxtOI7JQb_Z-Q_gMPXVPErFnBwuzq5-XM_jtgOcrxe_7gGLsRkX |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4oCi7saP2AeEWmi1pd0VQq3Um-skdsmB7LIPIf4Uv5GZPJZGSNwq5RRPXp7nF894AF7nmRlJZ3zs6pIcUkWjdR4LLnIe0lQaRz_0J1M1PhOfz-X5FvzuamEorbKzibWhLmY5_SPfJT8nyIHJD_MfMXWNotXVroVGIxbH_tdPhGzL90efkL9vkuTw4PTjOG67CsS5EHIVo4h7Ncw4Su5olFEL2FHhPAL7ofOeIyDMjdIhJGkmRRiawKWT3sjMpZQw6QuO970B24IjlBnA9v7B9MvXzboF-lveleZotbtE659Skq-M8UEJj3nP_dVdAv71BVecYT9R84rnO7wLd9qQle01MnYPtnx1H25O2kX5B1BSHl9bhMW-18mZnrXdKC5Z3WqHYWjM5gu6hNKsmcvXK8_QEDUx66pcIh3hAMQErKwYRqWs7JLrGWWnsTXanodwdi1z_QgG1azyT4Ah8AmqUDwEX6BICRcQ2blCBaMSXaQ8gnfdxNp5s1GHrQGOVrZhg0U22JoNFqn3ae43lLTJdn1itri0rc5a4XWGcNHlwWeEc51QLnOKpwVG1YWWEbwlzlkyBcie3LUVDfjCtKmW3dOJkZIaDkSw06NEFc77wx3vbWtClvavwEfwajNMV1JaXOVn65qGCyoXxls8bkRl80mC2vSNjI5A94So9839kar8Vm8wTi3oUzM0T___Xi_h1vh0cmJPjqbHz-B20og5HjswWC3W_jmGa6vsRasjDC6uWy3_AE5WU_o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Explainable+machine+learning+model+for+predicting+acute+pancreatitis+mortality+in+the+intensive+care+unit&rft.jtitle=BMC+gastroenterology&rft.au=Jiang%2C+Meng&rft.au=Xiao-peng%2C+Wu&rft.au=Xing-chen%2C+Lin&rft.au=Chang-li%2C+Li&rft.date=2025-03-03&rft.pub=BioMed+Central&rft.eissn=1471-230X&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12876-025-03723-3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon |